BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32029636)

  • 1. The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study.
    Mata-Cases M; Rodríguez-Sánchez B; Mauricio D; Real J; Vlacho B; Franch-Nadal J; Oliva J
    Diabetes Care; 2020 Apr; 43(4):751-758. PubMed ID: 32029636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resource use and costs in patients with poorly controlled type 2 diabetes mellitus and obesity in routine clinical practice in Spain.
    Díaz-Cerezo S; Romera I; Sicras-Mainar A; López-Simarro F; Dilla T; Artime E; Reviriego J
    Curr Med Res Opin; 2020 Sep; 36(9):1449-1456. PubMed ID: 32643441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct medical costs attributable to type 2 diabetes mellitus: a population-based study in Catalonia, Spain.
    Mata-Cases M; Casajuana M; Franch-Nadal J; Casellas A; Castell C; Vinagre I; Mauricio D; Bolíbar B
    Eur J Health Econ; 2016 Nov; 17(8):1001-1010. PubMed ID: 26542160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control.
    Seinfeld J; Sobrevilla A; Rosales ML; Ibáñez M; Ruiz D; Penny E; Londoño S
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jun; 24(5):661-669. PubMed ID: 38584495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and healthcare resource utilisation in the Kingdom of Bahrain.
    Salman RA; AlSayyad AS; Ludwig C
    BMC Health Serv Res; 2019 Dec; 19(1):939. PubMed ID: 31805932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a Telephonic Intervention to Improve Diabetes Control on Health Care Utilization and Cost for Adults in South Bronx, New York.
    Tabaei BP; Howland RE; Gonzalez JS; Chamany S; Walker EA; Schechter CB; Wu WY
    Diabetes Care; 2020 Apr; 43(4):743-750. PubMed ID: 32132009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain).
    Nuño-Solinís R; Alonso-Morán E; Arteagoitia Axpe JM; Ezkurra Loiola P; Orueta JF; Gaztambide S
    Endocrinol Nutr; 2016 Dec; 63(10):543-550. PubMed ID: 27825534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Anxiety With High-Cost Health Care Use Among Individuals With Type 2 Diabetes.
    Iturralde E; Chi FW; Grant RW; Weisner C; Van Dyke L; Pruzansky A; Bui S; Madvig P; Pearl R; Sterling SA
    Diabetes Care; 2019 Sep; 42(9):1669-1674. PubMed ID: 31213468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of social determinants, diabetes knowledge, health behaviors, and glycemic control in type 2 diabetes: an analysis from real-world evidence.
    Silva-Tinoco R; Cuatecontzi-Xochitiotzi T; De la Torre-Saldaña V; León-García E; Serna-Alvarado J; Orea-Tejeda A; Castillo-Martínez L; Gay JG; Cantú-de-León D; Prada D
    BMC Endocr Disord; 2020 Aug; 20(1):130. PubMed ID: 32843004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological trends and direct costs of diabetes in a Northern Italy area: 2012 health administrative records analysis LHT n. 20 Verona.
    Demurtas J; Alba N; Rigon G; Nesoti MV; Bovo C; Vaona A
    Prim Care Diabetes; 2017 Dec; 11(6):570-576. PubMed ID: 28663023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs.
    Mata-Cases M; Mahon J; Mauricio D; Franch-Nadal J; Real J; Hex N
    BMC Health Serv Res; 2020 Aug; 20(1):803. PubMed ID: 32847581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-monitoring of blood glucose: guideline application rather than utilization restrictions on testing strips has potential to reduce diabetes healthcare costs in Italy.
    Giaccari A; Grassi G; Ozzello A
    Diabetes Technol Ther; 2012 Oct; 14(10):862-7. PubMed ID: 22866825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care use and costs in the decade after identification of type 1 and type 2 diabetes: a population-based study.
    Johnson JA; Pohar SL; Majumdar SR
    Diabetes Care; 2006 Nov; 29(11):2403-8. PubMed ID: 17065675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal insulin persistence, associated factors, and outcomes after treatment initiation among people with type 2 diabetes mellitus in the US.
    Perez-Nieves M; Kabul S; Desai U; Ivanova JI; Kirson NY; Cummings AK; Birnbaum HG; Duan R; Cao D; Hadjiyianni I
    Curr Med Res Opin; 2016; 32(4):669-80. PubMed ID: 26703951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential short-term economic benefits of improved glycemic control: a managed care perspective.
    Menzin J; Langley-Hawthorne C; Friedman M; Boulanger L; Cavanaugh R
    Diabetes Care; 2001 Jan; 24(1):51-5. PubMed ID: 11194241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of type 2 diabetes medication cost sharing on patient outcomes and health plan costs.
    Thornton Snider J; Seabury S; Lopez J; McKenzie S; Goldman DP
    Am J Manag Care; 2016 Jun; 22(6):433-40. PubMed ID: 27355811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
    Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
    Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
    Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
    Clin Ther; 2007; 29 Spec No():1294-305. PubMed ID: 18046929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
    Mody R; Kalsekar I; Kavookjian J; Iyer S; Rajagopalan R; Pawar V
    J Diabetes Complications; 2007; 21(2):75-83. PubMed ID: 17331855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.